Hubei Biocause Pharmaceutical Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Public

  • Employees
  • 1,765

Employees

  • Stock Symbol
  • 000627

Stock Symbol

  • Investments
  • 5

  • Share Price
  • $0.34
  • (As of Friday Closing)

Hubei Biocause Pharmaceutical General Information

Description

Hubei Biocause Pharmaceutical Co Ltd is a China-based company engaged in life insurance, health insurance, accident insurance, and other life insurance businesses, medicine, and chemical businesses. The company generates its revenue in the form of premiums.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Other Chemicals and Gases
Stock Exchange
SHE
Corporate Office
  • No.122 Yangwan Road
  • Jingmen
  • Hubei, 448000
  • China
+86 027 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hubei Biocause Pharmaceutical Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.34 $0.33 $0.30 - $0.55 $1.68B 4.94B 29.6M -$0.02

Hubei Biocause Pharmaceutical Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 3,167,188 3,452,710 4,180,253 3,374,504
Revenue 6,329,358 7,024,695 7,367,347 7,678,887
EBITDA (299,987) (242,496) 55,245 73,882
Net Income (110,039) (92,123) 40,693 72,899
Total Assets 39,679,938 42,594,579 41,830,141 41,402,546
Total Debt 3,351,118 3,585,881 4,068,163 2,452,014
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hubei Biocause Pharmaceutical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hubei Biocause Pharmaceutical Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Granules Biocause Pharmaceuticals 04-Feb-2020 000000000 Drug Discovery
Guohua Life Insurance 30-Aug-2019 000000000 Life and Health Insurance
Guohua Life Insurance 22-Mar-2016 0000000000 00.000 Life and Health Insurance
AXA Tianping Property Insurance 10-Mar-2016 000000000 00000 Multi-line Insurance
Granules Biocause Pharmaceuticals 06-Mar-2007 Joint Venture Drug Discovery
To view Hubei Biocause Pharmaceutical’s complete investments and acquisitions history, request access »

Hubei Biocause Pharmaceutical Subsidiaries (2)

Company Name Industry Location Founded
Guohua Life Insurance Life and Health Insurance Shanghai, China 2007
Granules Biocause Pharmaceuticals Drug Discovery Jingmen, China 0000
To view Hubei Biocause Pharmaceutical’s complete subsidiaries history, request access »

Hubei Biocause Pharmaceutical ESG

Risk Overview

Risk Rating

Updated January, 24, 2024

39.46 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,421

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 928

Rank

00.00

Percentile

Pharmaceuticals

Subindustry

00 of 456

Rank

00.0

Percentile

To view Hubei Biocause Pharmaceutical’s complete esg history, request access »

Hubei Biocause Pharmaceutical Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
AXA Tianping Property Insurance 10-Mar-2016 000000000 00000000 00000 Completed
  • 00000 00000000 000
To view Hubei Biocause Pharmaceutical’s complete exits history, request access »

Hubei Biocause Pharmaceutical FAQs

  • When was Hubei Biocause Pharmaceutical founded?

    Hubei Biocause Pharmaceutical was founded in 1993.

  • Where is Hubei Biocause Pharmaceutical headquartered?

    Hubei Biocause Pharmaceutical is headquartered in Hubei, China.

  • What is the size of Hubei Biocause Pharmaceutical?

    Hubei Biocause Pharmaceutical has 1,765 total employees.

  • What industry is Hubei Biocause Pharmaceutical in?

    Hubei Biocause Pharmaceutical’s primary industry is Pharmaceuticals.

  • Is Hubei Biocause Pharmaceutical a private or public company?

    Hubei Biocause Pharmaceutical is a Public company.

  • What is Hubei Biocause Pharmaceutical’s stock symbol?

    The ticker symbol for Hubei Biocause Pharmaceutical is 000627.

  • What is the current stock price of Hubei Biocause Pharmaceutical?

    As of 17-May-2024 the stock price of Hubei Biocause Pharmaceutical is $0.34.

  • What is the current market cap of Hubei Biocause Pharmaceutical?

    The current market capitalization of Hubei Biocause Pharmaceutical is $1.68B.

  • What is Hubei Biocause Pharmaceutical’s current revenue?

    The trailing twelve month revenue for Hubei Biocause Pharmaceutical is $6.33B.

  • What is Hubei Biocause Pharmaceutical’s annual earnings per share (EPS)?

    Hubei Biocause Pharmaceutical’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »